Idexx Laboratories | IDXX - Cost Of Sales

Stock Price
652.83
Daily Change
9.84 1.53%
Monthly
0.11%
Yearly
35.91%
Q3 Forecast
637.65

Idexx Laboratories reported $414.72M in Cost of Sales for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 3.33B
Cash and Equivalent USD 164.59M
Cost of Sales USD 414.73M
Current Assets USD 1.36B
Current Liabilities USD 1.22B
Debt USD 1.24B
EBIT USD 373.05M
EBITDA USD 409.45M
Employees 11K
EPS Earnings Per Share USD 3.63
Equity Capital and Reserves USD -4.41B
Gross Profit on Sales USD 694.73M
Interest Expense on Debt USD 11.32M
Interest Income USD 627K
Loan Capital USD 449.81M
Market Capitalization USD 54.28B
Net Income USD 293.99M
Operating Expenses USD 736.41M
Operating Profit USD 373.05M
Ordinary Share Capital USD 80.42M
PE Price to Earnings USD 44.65
Pre-Tax Profit USD 362.35M
Sales Revenues USD 1.11B
Selling and Administration Expenses USD 259.79M
Stock USD 392.58M
Trade Creditors USD 116.59M
Trade Debtors USD 560.56M

Cost Of Sales Change Date
Abbott USD 5.27B 834M Jun/2025
Align Technology USD 304.33M 5.18M Jun/2025
Dentsply International USD 446M 33M Jun/2025
Dexcom USD 468.3M 21.3M Jun/2025
Edwards Lifesciences USD 344.4M 42.8M Jun/2025
Fujifilm JPY 436.91B 87.07B Jun/2025
Globus Medical USD 278.95M 83.56M Jun/2025
Henry Schein USD 2.29B 120M Jun/2025
Hologic USD 447.2M 2.6M Jun/2025
Idexx Laboratories USD 414.72M 39.68M Jun/2025
Insulet USD 196.9M 36.9M Jun/2025
Integra LifeSciences USD 206.27M 38.76M Jun/2025
Intuitive Surgical USD 822.1M 26.4M Jun/2025
Masimo USD 137.6M 400K Jun/2025
Neogen USD 132.6M 21.89M May/2025
ResMed USD 541.36M 16.04M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Steris USD 763.1M 76.22M Jun/2025
Tandem Diabetes Care USD 114.82M 1.19M Jun/2025
Teleflex USD 349.8M 38.57M Jun/2025
Thermo Fisher Scientific USD 6.81B 751M Jun/2025
Zoetis USD 682M 60M Jun/2025